(Prof. P.B. Farmer with Drs. D.J.L. Jones, R. Singh, K. Brown, K. McLuckie)
This section of the CBPG occupies a unique position within the UK academic environment by virtue of its expertise in xenobiotic interactions with cellular target sites as well as in the analysis of drugs and their metabolites in biological fluids. State of the art techniques available within the group include GC- and LC-MS-MS, HPLC with UV, fluorescent and electrochemical detection, 32P-postlabelling for determination of DNA damage, and immunoassay procedures for detection of DNA adducts.The group also has facilities for preparation of samples for, and access to, accelerator mass spectrometry (AMS), which is currently the most sensitive technique for the detection of isotopically labelled xenobiotics in biological systems.
CBP laboratory in the biocentre
CBPG laboratory in the Biocentre
One current emphasis of the group’s research is the involvement of radical-induced damage to DNA in biological effects of exogenously supplied chemicals. This approach is relevant to the identification of biomarkers of efficacy or potential toxicity of putative chemopreventive agents. The group also has extensive experience in identifying metabolite profiles for a wide range of compounds and techniques are being developed to study polymorphisms in drug activating and detoxifying enzymes.
The compounds of main interest to the Group are mutagenic or carcinogenic, and methodology has been developed to detect the interactions of genotoxic molecules with DNA and proteins as a marker of exposure to these compounds.  Sensitivity of detection of DNA adducts is below one adduct per 108 nucleotides.  The carcinogens of greatest interest at present are those from environmental or food sources, although occupational and medicinal exposures are also studied.  Detailed studies have been carried out, often involving extensive collaboration with EU scientists, on populations exposed to a variety of environmental and occupational genotoxins, including polycyclic aromatic hydrocarbons, low molecular weight olefins, styrene, benzene, and acrylonitrile.
 
Another current emphasis of the group’s research is the involvement of radical-induced damage to DNA in the biological effects of exogenously supplied chemicals. This approach is relevant to the identification of biomarkers of efficacy or potential toxicity of putative chemopreventive agents.  New approaches for determining oxidative DNA damage have been developed, and these are being applied to populations exposed both to environmental pollutants and to chemopreventive agents.
 

 

 

 

The relationship between adducts and biological significance is in most cases not completely understood.  To investigate this we are preparing carcinogen-modified oligonucleotides to study the mutagenic consequences of adduct formation.  Mutational events and repair of DNA lesions are being investigated in cells transfected with shuttle vector plasmids exposed to carcinogens, or with plasmids containing site-specific carcinogen adducts, in order to better understand the biological consequences of carcinogen induced DNA damage.

 
  | The  GroupOncology in Leicester  | Why Chemoprevention  |  Mechanisms  Section
| Biomonitoring Section  |  Pharmacology Section  |  Achievements  | News |  References  |  Contacts